Nivedita Tiwari, Ph.D.

Principal Research Scientist

Dr. Nivedita Tiwari, Ph.D., is an accomplished scientist with a remarkable 12-year journey marked by extensive research in the realm of Molecular and Cellular Biology. She brings a wealth of expertise to the biotech industry, boasting a distinguished track record of impactful publications in renowned journals such as Science Translational Medicine, the Journal of Pathology, the Journal of Virology, etc. Her outstanding contributions have earned her the esteemed American Heart Association Research Fellow Award. Dr. Tiwari's broad-ranging expertise encompasses the study of infectious and non-infectious diseases, with a particular emphasis on lung diseases. Her work includes in-depth investigations into viral respiratory infections, such as COVID-19, H1N1, Tuberculosis, and idiopathic pulmonary fibrosis. In her role as a senior research scientist at Novavax, she led a safety surveillance team for a protein-based COVID-19 vaccine project. This position leveraged her scientific acumen to drive the development of clinical research projects and commercial initiatives for vaccine and molecular assays, along with laboratory workflows.

During her tenure as a Post-Doctoral Research Fellow at The University of Texas Health Science Center, Dr. Tiwari's research in lung injury and tuberculosis infection demonstrated her profound knowledge and hands-on experience in immunological studies, multicolor flow cytometry, and metabolic functional assays. Dr. Tiwari's impressive academic background includes a Ph.D. in Biotechnology (Virology and Immunology) from the Sanjay Gandhi Post Graduate Institute of Medical Sciences in India. Her diverse skill set spans a wide spectrum, including cell culture, immunology, metabolomics, next-gen sequencing, molecular biology, cell biology, BSL3 laboratory work, and data analysis and visualization. Armed with a solid foundation in laboratory techniques and advanced assay development, Dr. Tiwari has presented her research findings at various national and international conferences. Her unwavering commitment to scientific advancement and outstanding contributions firmly establish her as a prominent figure in the biotech industry.

Nivedita Tiwari, Ph.D.

Principal Research Scientist

Dr. Nivedita Tiwari, Ph.D., is an accomplished scientist with a remarkable 12-year journey marked by extensive research in the realm of Molecular and Cellular Biology. She brings a wealth of expertise to the biotech industry, boasting a distinguished track record of impactful publications in renowned journals such as Science Translational Medicine, the Journal of Pathology, the Journal of Virology, etc. Her outstanding contributions have earned her the esteemed American Heart Association Research Fellow Award. Dr. Tiwari's broad-ranging expertise encompasses the study of infectious and non-infectious diseases, with a particular emphasis on lung diseases. Her work includes in-depth investigations into viral respiratory infections, such as COVID-19, H1N1, Tuberculosis, and idiopathic pulmonary fibrosis. In her role as a senior research scientist at Novavax, she led a safety surveillance team for a protein-based COVID-19 vaccine project. This position leveraged her scientific acumen to drive the development of clinical research projects and commercial initiatives for vaccine and molecular assays, along with laboratory workflows.

During her tenure as a Post-Doctoral Research Fellow at The University of Texas Health Science Center, Dr. Tiwari's research in lung injury and tuberculosis infection demonstrated her profound knowledge and hands-on experience in immunological studies, multicolor flow cytometry, and metabolic functional assays. Dr. Tiwari's impressive academic background includes a Ph.D. in Biotechnology (Virology and Immunology) from the Sanjay Gandhi Post Graduate Institute of Medical Sciences in India. Her diverse skill set spans a wide spectrum, including cell culture, immunology, metabolomics, next-gen sequencing, molecular biology, cell biology, BSL3 laboratory work, and data analysis and visualization. Armed with a solid foundation in laboratory techniques and advanced assay development, Dr. Tiwari has presented her research findings at various national and international conferences. Her unwavering commitment to scientific advancement and outstanding contributions firmly establish her as a prominent figure in the biotech industry.